Irccs San Raffaele Roma S.r.l.

The Medical Oncology department at Irccs San Raffaele Roma S.r.l. is conducting a trial that evaluates a novel daily therapy for patients with chronic hypoparathyroidism, aiming to improve calcium balance and reduce reliance on high‑dose vitamin D supplements.

• Daily eneboparatide dosing regimen
• Impact on serum calcium levels
• Reduction of supplemental calcium requirements
• Assessment of long‑term safety and tolerability

This study, located in Milan, seeks to provide a more convenient and effective treatment option for individuals living with this hormonal disorder.

A second investigation at the same site focuses on non‑small cell lung cancer (NSCLC), comparing an antibody‑drug conjugate with standard chemotherapy to determine whether overall survival can be extended for patients who have already received prior therapy.

• Overall survival comparison between experimental and control arms
• Evaluation of tumor response in previously treated NSCLC
• Safety and adverse‑event profiling of the new agent
• Exploration of predictive biomarkers for response

By enrolling participants in Milan, the trial aims to advance therapeutic options for this common thoracic malignancy.